Michael W. Lawlor

Michael W. Lawlor is a Professor of Pathology (Pediatric) at the Medical College of Wisconsin. He specializes in neuromuscular pathology, focusing on pediatric muscle diseases and gene therapy applications. His work includes clinical and research laboratories dedicated to diagnosing and treating disorders like Duchenne muscular dystrophy and X-linked myotubular myopathy. Lawlor has authored over 100 peer-reviewed publications and six book chapters, with recent studies emphasizing preclinical trial analyses and translational research.

Education: MD and PhD from Loyola University School of Medicine (2004), postdoctoral training at Boston Children's Hospital (2008).

Research Interests:

• Gene therapy for genetic muscle disorders
• Immunogenicity in enzyme replacement therapies
• Cardiac complications in muscular dystrophies
• Preclinical drug efficacy testing

Publications highlight collaborative industry partnerships, with recent work exploring nicorandil's cardioprotective effects and yoga's impact on mental health in clinical populations.

He directs diagnostic clinical laboratories for muscle/nerve biopsies and co-founded Diverge Translational Science Laboratory to advance therapy development for genetic disorders.